Modotuximab
Product Specifications
UNSPSC Description
Modotuximab (DS 1024) is an IgG1κ-type chimeric antibody targeting human EGFR protein. Modotuximab binds non-overlapping epitopes on domain III of EGFR, a domain that is intact in EGFRvIII. Modotuximab has antitumor activity in vivo[1].
Target Antigen
EGFR
Type
Inhibitory Antibodies
Related Pathways
JAK/STAT Signaling;Protein Tyrosine Kinase/RTK
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/modotuximab.html
Purity
99.08
Solubility
10 mM in DMSO
Smiles
[Namilumab]
References & Citations
[1]Keir
ST, et al. Sym004-induced EGFR
elimination is associated with profound anti-tumor activity in EGFRvIII
patient-derived glioblastoma models. J Neurooncol. 2018 Jul;138(3):489-498.|[2]Modotuximab. IMGT Database.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99306/Modotuximab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99306/Modotuximab-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
1310460-86-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
